Drugs / MD-Gastroview
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | MD-GASTROVIEW | — | 1981-09-02 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02928458 Comparator | Sep 2015 → Sep 2017 | intestinal obstruction | The Guthrie Clinic | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MD-Gastroview | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02928458 ↗ |
| Modality | Diagnostic / imaging agent | “Water soluble contrast (MD-Gastroview) has been shown to be both diagnostic and therapeutic in the management of ASBO” NCT02928458 ↗ |